CareDx (CDNA) director receives 1,746-share quarterly stock grant as compensation
Rhea-AI Filing Summary
Goldberg Michael reported acquisition or exercise transactions in this Form 4 filing.
CareDx, Inc. director Michael Goldberg reported an automatic equity grant and updated holdings. He received a grant of 1,746 shares of Common Stock at $0.00 per share as quarterly non-employee director compensation in lieu of cash under the company’s Outside Director Compensation Policy.
Following this grant, Goldberg holds 106,438 Common Stock shares directly. A separate entry shows 91,045 Common Stock shares held indirectly by the Cavallo Trust, for which Goldberg and his spouse serve as trustees. The filing reflects routine compensation and ownership reporting rather than open-market buying or selling.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,746 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
Footnotes (2)
- F1. Represents an automatic quarterly grant of common stock to the Reporting Person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.
- F2. Represents shares held by the Cavallo Trust of which the Reporting Person and the Reporting Person's spouse are trustees.
Key Figures
Key Terms
Form 4 regulatory
Common Stock financial
Outside Director Compensation Policy financial
non-employee director compensation financial
indirect ownership financial
Cavallo Trust financial
FAQ
What insider transaction did CareDx (CDNA) director Michael Goldberg report?
Was the CareDx (CDNA) Form 4 transaction an open-market purchase or sale?
What is the Cavallo Trust mentioned in the CareDx (CDNA) Form 4?
How is Michael Goldberg compensated as a non-employee director of CareDx (CDNA)?
AI-generated analysis. How Rhea-AI works. Not financial advice.